Close Menu

Books in a Library

H Shen

Treatment of One Case with Cryoglobulinaemia Secondary to Connective Tissue Disease by Small Doses of Rituximab



Objective: This study aims to observe the clinical efficacy of low-dose rituximab patients with cryoglobulinaemia secondary to connective tissue diseases.

Methods: Rituximab (100 mg) was infused in patients once a week for four weeks, combined with prednisone (20 mg) once a day and reduced regularly. The treatment effect was observed regularly.

06 Jan, 2015
PDF Attachment: 
Journal Sections: 
e-Published: 04 Apr, 2016

Mass Spectrometric Analysis of Cerebrospinal Fluid Protein for Glioma and its Clinical Applications

The combination of SELDI-TOF-MS and bioinformatics tools is a very effective method for screening and identifying new marker of glioma. The established diagnosis models have provided a new way for the clinical diagnosis of glioma, especially for qualitative diagnosis.


Objective: To establish and evaluate the fingerprint diagnostic models of cerebrospinal protein profile in glioma Using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) and bioinformatics analysis, for seeking new tumor markers.

18 May, 2015
PDF Attachment: 
Journal Sections: 
e-Published: 10 Nov, 2015


Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Subscribe to RSS - H Shen
Top of Page